Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileMyron Elmer Essex, Ph.D., D.V.M.

TitleMary Woodard Lasker Professor of Health Sciences
InstitutionHarvard T.H. Chan School of Public Health
DepartmentImmunology and Infectious Diseases
AddressHarvard School of Public Health
Dept of Immol & Infec. Dis. FXB 402
651 Huntington Ave
Boston MA 02115
Phone617/432-0975
vCardDownload vCard (login for email)
Other Positions
TitleMary Woodard Lasker Professor of Health Sciences, Harvard School of Public Health
InstitutionFaculty of Arts & Sciences
DepartmentFreshman Seminar


Collapse Mentoring 
Collapse completed student projects
A Comparison of HIV Seroprevalence Rates Between Single and Married Botswana Women
International, 06/22/99 - 08/26/99
Determining the Efficacy of ZDV for Reducing HIV-1 Transmission by Breast-feeding
Full Time/Year Long, 07/01/01 - 05/31/02
A Comparison of HIV Seroprevalence Rates Between Single and Married Botswana Women
International, 06/22/99 - 08/26/99

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
U2GGH001911     (ESSEX, MYRON E)Feb 1, 2016 - Jan 31, 2021
CDC/CGH
GH16-002, Botswana: Impact Evaluation of Combination HIV Prevention Interventions
Role: Principal Investigator

D43TW009610     (ESSEX, MYRON E)Aug 1, 2013 - Jan 31, 2018
NIH/FIC
Fogarty HIV Research Training Program for Low and Middle-Income Countries
Role: Principal Investigator

U01GH000447     (ESSEX, MYRON E)Sep 30, 2011 - Sep 29, 2015
CDC/CGH
Impact Evaluation of Combination HIV Prevention Interventions in Botswana
Role: Principal Investigator

RC4AI092715     (ESSEX, MYRON E)Sep 30, 2010 - Sep 29, 2013
NIH/NIAID
GWAS on Determinants of HIV-1 Subtype C Infection
Role: Principal Investigator

R01AI083036     (ESSEX, MYRON E)Sep 29, 2009 - Feb 28, 2014
NIH/NIAID
An HIV Prevention Program for Mochudi, Botswana
Role: Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Lin N, Gonzalez OA, Registre L, Becerril C, Etemad B, Lu H, Wu X, Lockman S, Essex M, Moyo S, Kuritzkes DR, Sagar M. Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants. EBioMedicine. 2016 Jun; 8:237-47. PMID: 27428434; PMCID: PMC4919596.
  2. Baum MK, Campa A, Page JB, Lai S, Tsalaile L, Martinez SS, Burns P, Williams O, Li Y, van Widenfelt E, Bussmann H, Sikhulele M, Makhema J, Essex M, Marlink R. Recruitment, Follow-Up and Characteristics of HIV Infected Adults who Use Illicit Drugs in Southern Africa. J Drug Abuse. 2015; 1(1). PMID: 26855969.
    View in: PubMed
  3. Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR, Suneja G, Kayembe MK, Mmalane M, Rebbeck T, Rider JR, Essex M, Lockman S. Correction: Cancer Incidence following Expansion of HIV Treatment in Botswana. PLoS One. 2015; 10(9):e0138742. PMID: 26376079; PMCID: PMC4573325.
  4. Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR, Suneja G, Kayembe MK, Mmalane M, Rebbeck T, Rider JR, Essex M, Lockman S. Cancer Incidence following Expansion of HIV Treatment in Botswana. PLoS One. 2015; 10(8):e0135602. PMID: 26267867; PMCID: PMC4534370.
  5. Novitsky V, Moyo S, Lei Q, DeGruttola V, Essex M. Impact of sampling density on the extent of HIV clustering. AIDS Res Hum Retroviruses. 2014 Dec; 30(12):1226-35. PMID: 25275430; PMCID: PMC4250956.
  6. Payne R, Muenchhoff M, Mann J, Roberts HE, Matthews P, Adland E, Hempenstall A, Huang KH, Brockman M, Brumme Z, Sinclair M, Miura T, Frater J, Essex M, Shapiro R, Walker BD, Ndung'u T, McLean AR, Carlson JM, Goulder PJ. Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence. Proc Natl Acad Sci U S A. 2014 Dec 16; 111(50):E5393-400. PMID: 25453107; PMCID: PMC4273423.
  7. Baum MK, Campa A, Lai S, Sales Martinez S, Tsalaile L, Burns P, Farahani M, Li Y, van Widenfelt E, Page JB, Bussmann H, Fawzi WW, Moyo S, Makhema J, Thior I, Essex M, Marlink R. Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trial. JAMA. 2013 Nov 27; 310(20):2154-63. PMID: 24281460; PMCID: PMC4347896.
  8. Lin NH, Becerril C, Giguel F, Novitsky V, Moyo S, Makhema J, Essex M, Lockman S, Kuritzkes DR, Sagar M. Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C. Virology. 2012 Nov 25; 433(2):296-307. PMID: 22954962; PMCID: PMC3616623.
  9. Lin NH, Smeaton LM, Giguel F, Novitsky V, Moyo S, Mitchell RM, Makhema J, Essex M, Lockman S, Kuritzkes DR. Prevalence and clinical associations of CXCR4-using HIV-1 among treatment-naive subtype C-infected women in Botswana. J Acquir Immune Defic Syndr. 2011 May 01; 57(1):46-50. PMID: 21346588; PMCID: PMC3353541.
  10. Baeten JM, Lingappa J, Beck I, Frenkel LM, Pepper G, Celum C, Wald A, Fife KH, Were E, Mugo N, Sanchez J, Essex M, Makhema J, Kiarie J, Farquhar C, Corey L. Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons. J Infect Dis. 2011 Jan 01; 203(1):117-21. PMID: 21148504; PMCID: PMC3024584.
  11. Lin NH, Negusse DM, Beroukhim R, Giguel F, Lockman S, Essex M, Kuritzkes DR. The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates. J Virol Methods. 2010 Oct; 169(1):39-46. PMID: 20599562; PMCID: PMC2930119.
  12. Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, Mujugira A, Mugo N, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, Essex M, Were E, Fife KH, de Bruyn G, Gray GE, McIntyre JA, Manongi R, Kapiga S, Coetzee D, Allen S, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Magaret AS, Wang RS, Kidoguchi L, Barnes L, Ridzon R, Corey L, Celum C. Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet. 2010 Mar 06; 375(9717):824-33. PMID: 20153888; PMCID: PMC2877592.
  13. Novitsky V, Wang R, Lagakos S, Essex M. HIV-1 Subtype C Phylodynamics in the Global Epidemic. Viruses. 2010 Jan; 2(1):33-54. PMID: 21994599; PMCID: PMC3185553.
  14. O'Neill E, Baugh LL, Novitsky VA, Essex ME, Garcia JV. Intra- and intersubtype alternative Pak2-activating structural motifs of human immunodeficiency virus type 1 Nef. J Virol. 2006 Sep; 80(17):8824-9. PMID: 16912329; PMCID: PMC1563850.
  15. Da'Dara AA, Lautsch N, Dudek T, Novitsky V, Lee TH, Essex M, Harn DA. Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice. Vaccine. 2006 Jun 12; 24(24):5211-9. PMID: 16675073.
    View in: PubMed
  16. Novitsky VA, Gilbert PB, Shea K, McLane MF, Rybak N, Klein I, Thior I, Ndung'u T, Lee TH, Essex ME. Interactive association of proviral load and IFN-gamma-secreting T cell responses in HIV-1C infection. Virology. 2006 May 25; 349(1):142-55. PMID: 16519915.
    View in: PubMed
  17. Sumida SM, Truitt DM, Lemckert AA, Vogels R, Custers JH, Addo MM, Lockman S, Peter T, Peyerl FW, Kishko MG, Jackson SS, Gorgone DA, Lifton MA, Essex M, Walker BD, Goudsmit J, Havenga MJ, Barouch DH. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein. J Immunol. 2005 Jun 01; 174(11):7179-85. PMID: 15905562.
    View in: PubMed
  18. Smith MW, Patterson N, Lautenberger JA, Truelove AL, McDonald GJ, Waliszewska A, Kessing BD, Malasky MJ, Scafe C, Le E, De Jager PL, Mignault AA, Yi Z, De The G, Essex M, Sankale JL, Moore JH, Poku K, Phair JP, Goedert JJ, Vlahov D, Williams SM, Tishkoff SA, Winkler CA, De La Vega FM, Woodage T, Sninsky JJ, Hafler DA, Altshuler D, Gilbert DA, O'Brien SJ, Reich D. A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet. 2004 May; 74(5):1001-13. PMID: 15088270; PMCID: PMC1181963.
  19. Popper SJ, Sarr AD, Guèye-Ndiaye A, Mboup S, Essex ME, Kanki PJ. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J Virol. 2000 Feb; 74(3):1554-7. PMID: 10627569; PMCID: PMC111493.
  20. Popper SJ, Sarr AD, Travers KU, Guèye-Ndiaye A, Mboup S, Essex ME, Kanki PJ. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J Infect Dis. 1999 Oct; 180(4):1116-21. PMID: 10479138.
    View in: PubMed
  21. Renjifo B, Blackard JT, Klaskala W, Chaplin BR, Shah P, McLane MF, Barin F, Esparza J, Zelaya JE, Osmanov S, Soto R, Fernandez JA, Baum MK, Essex ME. HIV-1 subtype B in Honduras. Virus Res. 1999 Apr; 60(2):191-7. PMID: 10392727.
    View in: PubMed
  22. Kanki PJ, Hamel DJ, Sankalé JL, Hsieh Cc, Thior I, Barin F, Woodcock SA, Guèye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, NDoye I, Essex ME, MBoup S. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis. 1999 Jan; 179(1):68-73. PMID: 9841824.
    View in: PubMed
  23. Sankalé JL, Mboup S, Essex ME, Kanki PJ. Genetic characterization of viral quasispecies in blood and cervical secretions of HIV-1- and HIV-2-infected women. AIDS Res Hum Retroviruses. 1998 Nov 01; 14(16):1473-81. PMID: 9824325.
    View in: PubMed
  24. Sarr AD, Hamel DJ, Thior I, Kokkotou E, Sankalé JL, Marlink RG, Coll-Seck EM, Essex ME, Siby T, NDoye I, Mboup S, Kanki PJ. HIV-1 and HIV-2 dual infection: lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts. AIDS. 1998 Jan 22; 12(2):131-7. PMID: 9468361.
    View in: PubMed
  25. Sankalé JL, De La Tour RS, Marlink RG, Scheib R, Mboup S, Essex ME, Kanki PJ. Distinct quasi-species in the blood and the brain of an HIV-2-infected individual. Virology. 1996 Dec 15; 226(2):418-23. PMID: 8955063.
    View in: PubMed
  26. Sankalé JL, de la Tour RS, Renjifo B, Siby T, Mboup S, Marlink RG, Essex ME, Kanki PJ. Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop. AIDS Res Hum Retroviruses. 1995 May; 11(5):617-23. PMID: 7576918.
    View in: PubMed
  27. Abbott RC, NDour-Sarr A, Diouf A, NDoye T, Bâ D, Tall N, MBaye N, Kébé F, Diadhiou F, Essex ME, et al. Risk factors for HIV-1 and HIV-2 infection in pregnant women in Dakar, Senegal. J Acquir Immune Defic Syndr. 1994 Jul; 7(7):711-7. PMID: 8207649.
    View in: PubMed
  28. Archibald DW, Zon LI, Groopman JE, Allan JS, McLane MF, Essex ME. Salivary antibodies as a means of detecting human T cell lymphotropic virus type III/lymphadenopathy-associated virus infection. J Clin Microbiol. 1986 Nov; 24(5):873-5. PMID: 3021816; PMCID: PMC269050.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu). FAS faculty should contact the Office for Scholarly Communication (oschulmail.harvard.edu) for general questions about Profiles. For data questions, please contact Raelyn Lincoln (raelyn_lincolnharvard.edu) from the FAS Division of Science; Jennifer Shephard (jmshephfas.harvard.edu) from the FAS Division of Social Science; or Alexander Parker (afparkerfas.harvard.edu) from the FAS Division of Arts and Humanities.
Essex's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_